Oncoinvent ASA Cash Flow Quality Index
Oncoinvent ASA cash flow quality index. Oncoinvent ASA (KLDVK) has a Cash Flow Quality Index of -0.56x as of December 2023. Operating cash flow of Nkr-40.23 Million is below net income of Nkr72.41 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore debt repayment capacity of Oncoinvent ASA to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Oncoinvent ASA (2021–2023)
Cash flow quality index of Oncoinvent ASA from 2021 to 2023. Historical Cash Flow Quality Index for Oncoinvent ASA across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. See KLDVK equity financing ratio to measure how much of total assets are equity-financed.
Oncoinvent ASA Cash Flow Quality Index by Year (2021–2023)
Oncoinvent ASA cash flow quality index by year from 2021 to 2023. Year-by-year earnings quality comparison for Oncoinvent ASA. For the full cash flow conversion analysis, see cash efficiency ratio of Oncoinvent ASA.
| Year | Quality Index | Operating CF (NOK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.56x | Nkr-40.23 Million | Nkr72.41 Million | ▼ -949.1% |
| 2021 | 0.07x | Nkr130.66K | Nkr2.00 Million | — |